Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Kathy O-Brien and Her Legacy in Oncology

Kathy O-Brien and Her Legacy in Oncology

After living with metastatic breast cancer for 12 years and leaving her mark on cancer services in America, Katherine O'Brien died on 19 June following a rapid decline in her health. She was 56. After being diagnosed in 2009 with metastatic breast cancer, O'Brien served as a patient advocate, blogger, essayist, reporter and mentor to doctors as well as patients.

Metastatic Cancers That People Do Not Want to Discuss

At patient forums, she was often actively silenced because she had "unbeatable" metastatic breast cancer, and she was a champion of people living with breast cancer. In a LinkedIn blog post in 2018, O'Brien wrote: “People often do not come closer to hear our stories… most run very, very far away.”

Known for her wit and generosity, O'Brien did not run away. With a large community of friends, collaborators and admirers, including many doctors, her @ihatebreastcanc account reached 4000 Twitter followers.

O'Brien's Twitter profile description read: "I am one of 168,000 people in the US living with metastatic breast cancer. I am ER/PR+ HER2- and currently on my 8th line of treatment." (I am one of 168,000 people in the USA living with metastatic breast cancer. I am ER/PR-positive and HER2-negative and am currently receiving my 8th line of treatment) 

Alongside her achievements in the cancer community, she may be best remembered for starting a national debate about the widespread practice in cancer clinics of ringing "victory" bells, and for encouraging the National Cancer Institute (NCI) finally to launch a project to count people with metastatic breast cancer in the United States, a population that had never been fully counted or statistically documented.

Tweets Mourning O'Brien

Dozens of people expressed their shock and sadness at her loss on social media. Don Dizon, of Brown University and Rhode Island Hospital in Providence, tweeted: "One of the first voices in the community of people with metastatic breast cancer whom I interacted with. She taught me so much. I am devastated."

Maryam Lustberg, of Yale Cancer Center in New Haven, Connecticut, tweeted that O'Brien had left "a remarkable legacy" .

Kelly Shanahan, who lives with stage 4 breast cancer in California, referred to O'Brien's project to count people living with metastatic breast cancer, tweeting: "She touched so many of us. One of the brightest writers, and her work to count us was so important and must continue".

Stephanie Graff, of the Lifelong Cancer Institute in Providence, Rhode Island, shared an anecdote about O'Brien approaching her for expert comment following a presentation at the San Antonio Breast Cancer Symposium. “About 4 seconds into my answer, she said, ‘I'm going to record this,’ and held a microphone up to my face. My first reaction, I won't lie, was, ‘Who is this blazing ball of courage?’ Then it was, ‘I really like this woman.’ Both impressions were right. Spirited & Amazing. Her advocacy lives on in memory.”

O'Brien first published a satire of pink culture in 2014: “Why can't every month be breast cancer awareness month?”

Every Month Is Every Cancer's Month

Physician Beverly Zavaleta tweeted, “Powerful, dark and funny,” about O'Brien's essay satirizing a commercialized awareness culture that ignores metastatic disease and turns breast cancer into a “speed rally.”

Referring to the mistreated donkey in the Winnie the Pooh stories, O'Brien wrote, "Obviously, the half a million people worldwide who will die of metastatic breast cancer this year are Eeyore-like losers—gloomy people with poor attitudes".

Zavaleta, author of the patient guide Braving Chemo, promised to keep O'Brien's voice "alive."

New York Times bestselling author and breast cancer survivor Peggy Orenstein praised KOB (as O'Brien sometimes signed emails to friends) on social media. "Katherine O'Brien, a wonderful writer, a fierce and effective advocate for people with metastatic breast cancer, and a woman of great wit and humor, died earlier this month. What could describe her better than her Twitter handle: @ihatebreastcanc.” she tweeted.

Cancer Treatment Continues in a World Stopped by Covid-19

Although O'Brien's relationships revealed a highly sociable person, she also knew the invisibility and loneliness of living with metastatic disease, especially during the Covid-19 Pandemic, and was not afraid to portray them. During the pandemic, in the months before her death, she tweeted photographs and posts from empty train stations and mostly empty carriages while traveling from suburban Chicago to Northwestern University for chemotherapy.

Deanna Attai, of UCLA Jonsson Comprehensive Cancer Center in Los Angeles, applauded this form of advocacy and education. Attai said, “The world was in lockdown, but cancer treatment continued. I found these posts both heartbreaking and inspiring”.

O'Brien was not the first person to write about the insensitivity of celebratory bell-ringing ceremonies that mark the end of chemotherapy or radiation treatment for patients with early-stage disease in cancer clinics. For example, in 2018, Medscape commentator John Marshall of Georgetown University in Washington DC observed that these celebrations could "isolate" those who were "less fortunate" (meaning patients with metastatic disease).

Sources

Mulcahy N. (02.07.2021). Kathy O'Brien, Who Started Debate on Cancer Bell Ringing, Dies at 56. Medscape

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Kathy O-Brien and Her Legacy in Oncology

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy